Your browser doesn't support javascript.
loading
Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses.
Walter, Frederik; Winter, Elsa; Rahn, Sascha; Heidland, Judith; Meier, Saskia; Struzek, Anna-Maria; Lettau, Marcus; Philipp, Lisa-Marie; Beckinger, Silje; Otto, Lilli; Möller, Julia Luisa; Helm, Ole; Wesch, Daniela; Scherließ, Regina; Sebens, Susanne.
Afiliação
  • Walter F; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
  • Winter E; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
  • Rahn S; Institute of Biochemistry, Kiel University, Kiel, Germany.
  • Heidland J; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.
  • Meier S; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.
  • Struzek AM; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.
  • Lettau M; Institute of Immunology, Kiel University and UKSH Campus Kiel, Kiel, Germany.
  • Philipp LM; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
  • Beckinger S; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
  • Otto L; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
  • Möller JL; Department of Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
  • Helm O; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
  • Wesch D; Institute of Immunology, Kiel University and UKSH Campus Kiel, Kiel, Germany.
  • Scherließ R; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.
  • Sebens S; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
PLoS One ; 15(9): e0239369, 2020.
Article em En | MEDLINE | ID: mdl-32997691
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Linfócitos T CD8-Positivos / Quitosana / Nanopartículas / Antígenos de Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Linfócitos T CD8-Positivos / Quitosana / Nanopartículas / Antígenos de Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article